12:00 AM
Jun 11, 2012
 |  BC Week In Review  |  Company News  |  Other News

ExonHit, OSEO cancer news

ExonHit said it received €1.9 million ($2.4 million) in funding under the Strategic Industrial Innovation program from France's OSEO agency. The funding was awarded for ExonHit's participation in a consortium to develop therapies to treat chemo- and...

Read the full 165 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >